It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
STUDY QUESTION
Is there an association between changes in endometrial thickness (EMT) following progesterone administration and pregnancy outcomes in frozen-thawed embryo transfers (FETs) at Day 3 (D3) and blastocyst stages?
SUMMARY ANSWER
Endometrial compaction is not associated with better pregnancy outcomes.
WHAT IS KNOWN ALREADY
Previous studies have shown conflicting results on the impact of EMT changes on FET outcomes.
STUDY DESIGN, SIZE, DURATION
This study was a single-center retrospective cohort analysis of FETs from 1 January 2018 to 31 December 2022. A total of 9390 D3 FETs and 7063 blastocyst FETs were included during this period.
PARTICIPANTS/MATERIALS, SETTING, METHODS
D3 FETs and blastocyst FETs were divided into three groups: compaction group, non-change group, and expansion group. The impact of EMT changes after progesterone administration on HCG-positive, pregnancy, ongoing pregnancy, live birth, and pregnancy loss rates were analyzed for D3 and blastocyst FETs. EMT on the progesterone administration day (defined as EMT1) and on embryo transfer (ET)day (defined as EMT2) was measured exclusively by transvaginal ultrasound. Inverse probability weighting (IPW) and stratified logistic regressions were conducted to reduce the effects of confounding factors.
MAIN RESULTS AND THE ROLE OF CHANCE
After IPW adjustment, in D3 FETs, women with compacted endometrium had the lowest HCG-positive rates (P = 0.012), clinical pregnancy rates (P < 0.001), ongoing pregnancy rates (P < 0.001), and live birth rates (LBRs) (P < 0.001) among the three groups. Among HCG-positive cases, the compaction group had the highest ectopic pregnancy rates (3.5% vs 2.6% vs 1.6%; P = 0.015) and the lowest LBRs (65.8% vs 68.3% vs 71.4%; P = 0.018). Univariate logistic regressions found that LBRs were weakly associated with compacted endometrium [odds ratio (OR) 0.831, 95% CI: 0.696–0.993]. Logistic regressions with IPW revealed that the compaction group was not associated with higher odds of pregnancy outcomes, including HCG positive, clinical pregnancy, ongoing pregnancy, ongoing pregnancy, and live births compared to the non-change group. In contrast, the expansion group was associated with higher odds of live birth per ETs (OR 1.166, 95% CI: 1.070–1.271; P = 0.001), and live birth per HCG-positive cases (OR 1.160, 95% CI: 1.028–1.309; P = 0.016). In blastocyst FETs, women with compacted endometrium had the lowest HCG-positive rates (P = 0.001) and clinical pregnancy rates (P = 0.031). Logistic regressions with IPW adjustment found that compaction group was associated with lower odds of HCG positive (OR 0.813, 95% CI: 0.668–0.989, P = 0.039) compared to the non-change group. Additionally, LBRs increased with the rising change ratios of EMT after progesterone administration, but within a certain range (30% in D3 FETs and 50% in blastocyst FETs).
LIMITATIONS, REASONS FOR CAUTION
This study only included retrospective analyses of untested embryos for FETs.
WIDER IMPLICATIONS OF THE FINDINGS
Endometrial expansion in D3 FETs exhibited a positive association with improved LBRs, but not in blastocyst FETs. These findings suggest that embryo developmental stage-specific endometrial preparation protocols may enhance assisted reproductive outcomes.
STUDY FUNDING/COMPETING INTEREST(S)
This study was supported by National Natural Science Foundation of China (82201856), Basic Scientific Research project of Wenzhou Science and Technology Bureau (Y20220006), Wenzhou Key Laboratory of Reproduction and Genetics (2022HZSY0051), and Clinical Technology International Exchange Project of Zhejiang Provincial Medical Institutions. The authors have no conflicts of interest to declare.
TRIAL REGISTRATION NUMBER
N/A.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Reproductive Medicine Center, The First Affiliated Hospital of Wenzhou Medical University , Wenzhou, Zhejiang, China
2 Traditional Chinese Medicine Department, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University , Wenzhou, Zhejiang, China